STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

BREAKTHROUGH T1D: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
BREAKTHROUGH T1D (EIN 23-1907729)
Tax period
2019-07-01 to 2020-06-30
Filed
2021-04-08
IRS object ID
202140989349301304
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-04-08T14:41:14-05:00ReturnTs
Tax Period End2020-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1KPMG LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1345 PARK AVEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10154ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN231907729EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1JDRF INTERNATIONALBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% EMMA PANGILINAN-ROSALESInCareOfNm
Business Name ControlJDRFBusinessNameControlTxt
Phone2126892860PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1200 VESEY STREET 28TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10281ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonJOANNE MARTZPersonNm
Person TitleCFOPersonTitleTxt
Phone2124797550PhoneNum
Signature2021-04-05SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonEVAN W SEEKAMPPreparerPersonNm
PTINP01907071PTIN
Phone2127589700PhoneNum
Preparation2021-04-05PreparationDt
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerAARON KOWALSKIPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1200 VESEY STREET 28TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10281ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$274,899,230GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.jdrf.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1970FormationYr
Legal Domicile StatePALegalDomicileStateCd
Activity Or MissionImproving lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications. SEE SCHEDULE O, ATTACH. 1.ActivityOrMissionDesc
Voting Members Governing Body13VotingMembersGoverningBodyCnt
Voting Members Independent13VotingMembersIndependentCnt
Total Employee868TotalEmployeeCnt
Total Volunteers235000TotalVolunteersCnt
Total Gross UBI$49,734TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$29,579NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$215,659,011PYContributionsGrantsAmt
CY Contributions Grants$194,074,339CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$19,973,309PYInvestmentIncomeAmt
CY Investment Income$16,238,938CYInvestmentIncomeAmt
PY Other Revenue$3,697,145PYOtherRevenueAmt
CY Other Revenue$2,289,173CYOtherRevenueAmt
PY Total Revenue$239,329,465PYTotalRevenueAmt
CY Total Revenue$212,602,450CYTotalRevenueAmt
PY Grants And Similar Paid$89,137,491PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$68,847,301CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$80,309,185PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$77,701,531CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$339,984PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$27,446CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$34,666,848CYTotalFundraisingExpenseAmt
PY Other Expenses$42,783,392PYOtherExpensesAmt
CY Other Expenses$46,029,373CYOtherExpensesAmt
PY Total Expenses$212,570,052PYTotalExpensesAmt
CY Total Expenses$192,605,651CYTotalExpensesAmt
PY Revenues Less Expenses$26,759,413PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$19,996,799CYRevenuesLessExpensesAmt
Total Assets BOY$244,434,766TotalAssetsBOYAmt
Total Assets EOY$268,023,077TotalAssetsEOYAmt
Total Liabilities BOY$128,633,286TotalLiabilitiesBOYAmt
Total Liabilities EOY$134,322,376TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$115,801,480NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$133,700,701NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionAT JDRF, WE WORK TIRELESSLY TO ACCELERATE BREAKTHROUGHS TO CURE, PREVENT AND TREAT TYPE 1 DIABETES (T1D). WE CONTINUALLY EXPAND OUR SCIENTIFIC KNOWLEDGE, OUR CONNECTIONS AND COLLABORATIONS, OUR PARTNERS AND GLOBAL PRESENCE TO UNLOCK THE SCIENCE THAT WILL STOP T1D. WHILE WE FIGHT FOR A CURE, WE STRIVE JUST AS HARD TO DEVELOP THERAPIES TO HELP PEOPLE RIGHT NOW. JDRF AND OUR SCIENTISTS ARE LEADING T1D RESEARCH AROUND THE WORLD. WE ADDRESS KEY GAPS TO MOVE RESEARCH FASTER AND FARTHER ACROSS THE DEVELOPMENT PIPELINE AND TO TRANSLATE BREAKTHROUGHS INTO NEW THERAPIES FOR PEOPLE WITH T1D. THIS ENABLES US TO ADVANCE SCIENCE WITH THE MOST POTENTIAL AND TO DRIVE RESEARCH THAT ATTRACTS MORE RESOURCES AND SCIENTIFIC EXPERTISE TO THE FIELD. WE INVEST IN THE EARLY STAGES, ALLOWING RESEARCHERS TO PURSUE INNOVATIVE IDEAS AND APPROACHES THAT WILL LEAD TO BREAKTHROUGH TREATMENTS. JDRF ALSO WORKS TO DRIVE NEW THERAPIES AND TECHNOLOGIES TO MARKET SO THEY GET INTO THE HANDS OF PEOPLE WITH T1D MORE QUICKLY.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$68,847,301ExpenseAmt
Grant$68,847,301GrantAmt
DescRESEARCH FUNDING - FOR THE FY20 PERIOD ENDING JUNE 30, 2020, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $69 MILLION IN RESEARCH GRANT EXPENSE, NET WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $50 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS WHICH ARE RECORDED TO THE ORGANIZATION'S BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$16,997,889ExpenseAmt
DescRESEARCH SUPPORT - JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO RESEARCH SUPPORT, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$50,681,132ExpenseAmt
DescPUBLIC EDUCATION AND OUTREACH - JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES AND OTHERS ABOUT T1D AND ITS COMPLICATIONS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH, SEE SCHEDULE O.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$136,526,322TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstYes (true)ReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesYes (true)GamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityYes (true)DisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document1014IRPDocumentCnt
IRP Document W2 G6IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee868EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryISForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Form1098 C FiledYes (true)Form1098CFiledInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members13GoverningBodyVotingMembersCnt
Independent Voting Member13IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VentureYes (true)InvestmentInJointVentureInd
Written Policy Or ProcedureYes (true)WrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldIDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldIAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTXStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWYStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonEMMA PANGILINAN-ROSALESPersonNm
Phone2124797550PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1200 VESEY STREET 28TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10281ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
DEREK RAPP THRU 0419
PRESIDENT AND CEO0.00.0Yes (X)$870,371$0$11,538
AARON KOWALSKI
PRESIDENT AND CEO50.00.0$654,519$0$46,292Yes (X)
HELEN ELIAS
MANAGING DIR. JDRF T1D FUND50.00.0$450,498$0$25,833Yes (X)
SANDRA HIJIKATA THRU 0420
CHIEF DEV OFFICER & ASST. SECY50.00.0$450,550$0$24,944Yes (X)
JOANNE MARTZ
CFO/TREASURER50.00.0$416,133$0$34,916Yes (X)
ALISA NORRIS
CHIEF MARKETING OFFICER50.00.0$375,000$0$46,988Yes (X)
CYNTHIA RICE
CHIEF MISSION OFFICER50.00.0$370,834$0$31,152Yes (X)
SRINIVAS MISHRA
CHIEF DATA AND TECHNOLOGY50.00.0$363,067$0$34,061Yes (X)
SUSAN YUN THRU 0520
CHIEF PEOPLE OFFICER/ASST. SEC50.00.0$373,433$0$14,973Yes (X)
JILL CLARK
SVP, VOLUNTEER ENGAGEMENT50.00.0$359,900$0$19,588Yes (X)
SANJOY DUTTA
VP, RESEARCH50.00.0$286,171$0$16,155Yes (X)
SYDNEY YOVIC
CHIEF OF STAFF/ASST. TREASURER50.00.0$185,085$0$32,984Yes (X)
JAMES MCDONALD
BOARD LIAISON/SECRETARY50.00.0$109,130$0$6,065Yes (X)
ELLEN LEAKE
CHAIR OF THE BOARD20.00.0$0$0$0Yes (X)Yes (X)
MARGERY PERRY
CHAIR, RESEARCH5.00.0$0$0$0Yes (X)
LISA WALLACK
BOARD MEMBER5.00.0$0$0$0Yes (X)
PAUL HEATH
CHAIR, ADVOCACY & IMPACT3.00.0$0$0$0Yes (X)
JEFF PLUMER
BOARD VICE-CHAIR10.00.0$0$0$0Yes (X)Yes (X)
GRANT BEARD
CHAIR, AUDIT & RISK COMMITTEE5.00.0$0$0$0Yes (X)
STEVEN DAVIS
CHAIR, NOMINATING & GOVERNANCE3.00.0$0$0$0Yes (X)
JOE LACHER
CHAIR, TALENT & COMPENSATION5.00.0$0$0$0Yes (X)
JENNIFER SCHNEIDER MD
BOARD MEMBER3.00.0$0$0$0Yes (X)
MATT VAREY
BOARD MEMBER3.00.0$0$0$0Yes (X)
CHRISTOPHER TURNER
CHAIR, FINANCE & INVESTMENTS5.00.0$0$0$0Yes (X)
MICHAEL ALTER
CHAIR, FUNDING COMMITTEE3.00.0$0$0$0Yes (X)
CLAUDIA GRAHAM
BOARD MEMBER3.00.0$0$0$0Yes (X)
TROY LINDLOFF BEGAN 0220
CDO/ASST. TREASURER50.00.0$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,264,691TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$345,489TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K201IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNmCountryContractorAddress/ForeignAddress/CountryCd
BLUE STATE DIGITAL
41 FLATBUSH AVEBROOKLYNNY11217WEB DEVELOPMENT$1,903,583
KAVYOS CONSULTING INC
485 US-1ISELINNJ08830IT CONSULTANTS$1,663,170
JOHN GALLIN SON INC
102 MADISON AVE 9TH FLNEW YORKNY10016GENERAL CONTRACTOR$2,541,820
INNOVATION CLOUD LLC
IT CONSULTANTS$1,336,808RUE DE LINDUSTRIE 15 L-8069BERTRANGE0LU
MED-IQ LLC
5523 RESEARCH PARK DR STE 210BALTIMOREMD21228PROF. CONSULTANTS$482,886
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K34CntrctRcvdGreaterThan100KCnt
Federated Campaigns$3,973,328FederatedCampaignsAmt
Fundraising$109,565,253FundraisingAmt
All Other Contributions$80,535,758AllOtherContributionsAmt
Noncash Contributions$12,160,404NoncashContributionsAmt
Total Contributions$194,074,339TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,968,472TotalRevenueColumnAmt
Unrelated Business Revenue$49,734UnrelatedBusinessRevenueAmt
Exclusion$2,918,738ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$57,078,984SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$43,808,518SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$13,270,466SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$13,270,466TotalRevenueColumnAmt
Exclusion$13,270,466ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$18,254,759FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$109,565,252ContriRptFundraisingEventAmt
Fundraising Direct Expenses$18,254,759FundraisingDirectExpensesAmt
Gaming Gross Income$850,956GamingGrossIncomeAmt
Gaming Direct Expenses$233,503GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$617,453TotalRevenueColumnAmt
Exclusion$617,453ExclusionAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMISC REVENUEDesc
Business900099BusinessCd
Total Revenue Column$1,671,720TotalRevenueColumnAmt
Exclusion$1,671,720ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$1,671,720OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$212,602,450TotalRevenueColumnAmt
Unrelated Business Revenue$49,734UnrelatedBusinessRevenueAmt
Exclusion$18,478,377ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$47,676,980TotalAmt
Program Services$47,676,980ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$21,170,321TotalAmt
Program Services$21,170,321ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,271,140TotalAmt
Program Services$1,362,684ProgramServicesAmt
Management And General$317,960ManagementAndGeneralAmt
Fundraising$590,496FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$59,971,320TotalAmt
Program Services$33,919,245ProgramServicesAmt
Management And General$10,585,372ManagementAndGeneralAmt
Fundraising$15,466,703FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$10,155,549TotalAmt
Program Services$5,805,316ProgramServicesAmt
Management And General$1,610,683ManagementAndGeneralAmt
Fundraising$2,739,550FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$5,303,522TotalAmt
Program Services$2,848,001ProgramServicesAmt
Management And General$987,183ManagementAndGeneralAmt
Fundraising$1,468,338FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$2,448,293TotalAmt
Program Services$1,334,249ProgramServicesAmt
Management And General$154,938ManagementAndGeneralAmt
Fundraising$959,106FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$520,511TotalAmt
Program Services$153,799ProgramServicesAmt
Management And General$260,220ManagementAndGeneralAmt
Fundraising$106,492FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$254,540TotalAmt
Management And General$254,540ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$853,826TotalAmt
Program Services$853,826ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$27,446TotalAmt
Fundraising$27,446FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$319,620TotalAmt
Management And General$319,620ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$3,924,455TotalAmt
Program Services$1,743,975ProgramServicesAmt
Management And General$1,020,688ManagementAndGeneralAmt
Fundraising$1,159,792FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$4,718,131TotalAmt
Program Services$2,545,090ProgramServicesAmt
Management And General$313,831ManagementAndGeneralAmt
Fundraising$1,859,210FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$1,676,281TotalAmt
Program Services$894,241ProgramServicesAmt
Management And General$365,257ManagementAndGeneralAmt
Fundraising$416,783FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$6,524,385TotalAmt
Program Services$2,595,691ProgramServicesAmt
Management And General$1,261,834ManagementAndGeneralAmt
Fundraising$2,666,860FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$8,966,787TotalAmt
Program Services$4,696,657ProgramServicesAmt
Management And General$1,682,529ManagementAndGeneralAmt
Fundraising$2,587,601FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$2,882,582TotalAmt
Program Services$1,745,565ProgramServicesAmt
Management And General$301,825ManagementAndGeneralAmt
Fundraising$835,192FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$1,175,240TotalAmt
Program Services$465,852ProgramServicesAmt
Management And General$201,827ManagementAndGeneralAmt
Fundraising$507,561FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$45,282TotalAmt
Program Services$45,282ProgramServicesAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$4,192,966TotalAmt
Program Services$1,423,148ProgramServicesAmt
Management And General$887,956ManagementAndGeneralAmt
Fundraising$1,881,862FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$612,366TotalAmt
Program Services$261,320ProgramServicesAmt
Management And General$193,328ManagementAndGeneralAmt
Fundraising$157,718FundraisingAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
OUTREACH EXPENSES$5,189,866$3,994,526$414,210$781,130
DUES & FEES$831,976$453,321$159,919$218,736
OTHER MISC EXPENSES$892,266$537,233$118,761$236,272

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$192,605,651TotalAmt
Program Services$136,526,322ProgramServicesAmt
Management And General$21,412,481ManagementAndGeneralAmt
Fundraising$34,666,848FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$2,005,061TotalAmt
Program Services$501,444ProgramServicesAmt
Fundraising$1,503,616FundraisingAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XYes (X)InfoInScheduleOPartXInd

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$19,125,818BOYAmt
EOY$18,028,084EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$36,566,833BOYAmt
EOY$29,732,492EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$30,267,097BOYAmt
EOY$36,176,968EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$20,525,959BOYAmt
EOY$7,962,575EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$6,720,000BOYAmt
EOY$3,870,000EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$6,103,129BOYAmt
EOY$7,022,535EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$15,578,062LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$4,173,382LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$5,895,032BOYAmt
EOY$11,404,680EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$93,573,878BOYAmt
EOY$102,925,827EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$4,213,073BOYAmt
EOY$857,686EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$21,443,947BOYAmt
EOY$50,042,230EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$244,434,766BOYAmt
EOY$268,023,077EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$16,774,462BOYAmt
EOY$24,845,175EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$100,065,608BOYAmt
EOY$99,239,193EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$9,232,753BOYAmt
EOY$7,730,761EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,560,463BOYAmt
EOY$2,507,247EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$128,633,286BOYAmt
EOY$134,322,376EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$76,838,325BOYAmt
EOY$85,538,657EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$38,963,155BOYAmt
EOY$48,162,044EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$115,801,480BOYAmt
EOY$133,700,701EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$244,434,766BOYAmt
EOY$268,023,077EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$19,996,799ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$2,097,578NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$196,804,267CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$199,896,852CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$219,968,105CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$215,659,011CurrentTaxYearMinus1YearAmt
Current Tax Year$194,074,339CurrentTaxYearAmt
Total$1,026,402,574TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$196,804,267CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$199,896,852CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$219,968,105CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$215,659,011CurrentTaxYearMinus1YearAmt
Current Tax Year$194,074,339CurrentTaxYearAmt
Total$1,026,402,574TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$0SubstantialContributorsTotAmt
Public Support Total170$1,026,402,574PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$465,379CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$548,825CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,309,523CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,439,225CurrentTaxYearMinus1YearAmt
Current Tax Year$2,918,738CurrentTaxYearAmt
Total$7,681,690TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$112,437CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$33,150CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$138,747CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$186,965CurrentTaxYearMinus1YearAmt
Current Tax Year$29,579CurrentTaxYearAmt
Total$500,878TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$94,769CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$283,014CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,793,044CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,313,482CurrentTaxYearMinus1YearAmt
Current Tax Year$1,671,720CurrentTaxYearAmt
Total$6,156,029TotalAmt
FieldValueIRS element (for citing)
Total Support$1,040,741,171TotalSupportAmt
Public Support CY1700.98622PublicSupportCY170Pct
Public Support PY1700.98740PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
Form4720 FiledfalseForm4720FiledInd
VolunteersYes (true)VolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsYes (true)MediaAdvertisementsInd
Media Advertisements$16,450MediaAdvertisementsAmt
Mailings MembersfalseMailingsMembersInd
Mailings Members$0MailingsMembersAmt
Publications Or BroadcastYes (true)PublicationsOrBroadcastInd
Publications Or Broadcast$17,625PublicationsOrBroadcastAmt
Grants Other OrganizationsYes (true)GrantsOtherOrganizationsInd
Grants Other Organizations$2,343GrantsOtherOrganizationsAmt
Direct Contact LegislatorsYes (true)DirectContactLegislatorsInd
Direct Contact Legislators$526,529DirectContactLegislatorsAmt
Rallies DemonstrationsYes (true)RalliesDemonstrationsInd
Rallies Demonstrations$462,701RalliesDemonstrationsAmt
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$1,147OtherActivitiesAmt
Total Lobbying Expenditures$1,026,795TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceJDRF LOBBYING ACTIVITIESFormAndLineReferenceDesc
ExplanationFORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization funding type 1 diabetes (T1D) research, focused on curing T1D and improving lives. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance development and access to therapies to cure T1D and help people stay as healthy as possible until that day. JDRF has been instrumental in securing the renewal of the Special Diabetes Program, which provides $150MM annually for T1D research at the National Institutes of Health. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation.ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,887,833BeginningYearBalanceAmt
Contributions-$140,727ContributionsAmt
Investment Earnings Or Losses$33,086InvestmentEarningsOrLossesAmt
Other Expenditures$71,023OtherExpendituresAmt
End Year Balance$7,709,169EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,567,601BeginningYearBalanceAmt
Contributions$221,441ContributionsAmt
Investment Earnings Or Losses$102,034InvestmentEarningsOrLossesAmt
Other Expenditures$3,243OtherExpendituresAmt
End Year Balance$7,887,833EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,341,367BeginningYearBalanceAmt
Investment Earnings Or Losses$268,304InvestmentEarningsOrLossesAmt
Other Expenditures$42,070OtherExpendituresAmt
End Year Balance$7,567,601EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,176,427BeginningYearBalanceAmt
Investment Earnings Or Losses$367,446InvestmentEarningsOrLossesAmt
Other Expenditures$202,506OtherExpendituresAmt
End Year Balance$7,341,367EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,141,514BeginningYearBalanceAmt
Investment Earnings Or Losses$37,913InvestmentEarningsOrLossesAmt
Other Expenditures$3,000OtherExpendituresAmt
End Year Balance$7,176,427EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.00000BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY1.00000PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$5,269,771OtherCostOrOtherBasisAmt
Depreciation$4,783,263DepreciationAmt
Book Value$486,508BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$15,578,062OtherCostOrOtherBasisAmt
Depreciation$4,659,890DepreciationAmt
Book Value$10,918,172BookValueAmt
FieldValueIRS element (for citing)
Other Land BuildingsOtherLandBuildingsGrp
Total Book Value Land Buildings$11,404,680TotalBookValueLandBuildingsAmt

Invst Program Related Org InvstProgramRelatedOrgGrp

FieldValueIRS element (for citing)
DescT1D FUND PROGRAM RELATED INVESDesc
Book Value$50,042,230BookValueAmt
Method ValuationFMethodValuationCd
FieldValueIRS element (for citing)
Total Book Value Program Rltd$50,042,230TotalBookValueProgramRltdAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescSPLIT INTEREST CHRT RMDR TRUSTDesc
Amt$2,507,247Amt
FieldValueIRS element (for citing)
Total Liability$2,507,247TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$210,185,251TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$2,097,579NetUnrealizedGainsInvstAmt
Revenue Not Reported-$2,097,579RevenueNotReportedAmt
Revenue Subtotal$212,282,830RevenueSubtotalAmt
Investment Expenses Not Incld$319,620InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$319,620RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$212,602,450TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$192,286,031TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal$192,286,031ExpensesSubtotalAmt
Investment Expenses Not Incld2$319,620InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$319,620ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$192,605,651TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
ORGANIZATION'S ENDOWMENT FUNDSFORM 990, PART X, LINE 28 & 29 & SCH D, PART V THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATIONS GENERAL EXEMPT PURPOSE.
UNCERTAIN TAX POSITIONS990 SCH-D, PART X, LINE 2 JDRF IS A NOT FOR PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501 (C) (3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. THE EFFECT OF INCOME INCOME TAX POSITIONS IS RECOGNIZED ONLY IF THE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRF'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2020 AND 2019.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmtOfficesOfficesCntEmployeeEmployeeCnt
East Asia and the PacificGrantmakingRESEARCH GRANTS$5,200,123
Europe (Including Iceland and Greenland)GrantmakingRESEARCH GRANTS$12,596,152
Middle East and North AfricaGrantmakingRESEARCH GRANTS$761,742
North AmericaGrantmakingRESEARCH GRANTS$2,032,241
South AsiaGrantmakingRESEARCH GRANTS$618,750
Central America and the CaribbeanInvestmentsINVESTMENTS$28,320
Europe (Including Iceland and Greenland)Program ServicesRESEARCH SUPPORT$537,61622
FieldValueIRS element (for citing)
Subtotal Offices2SubtotalOfficesCnt
Subtotal Employees2SubtotalEmployeesCnt
Total Office2TotalOfficeCnt
Total Employee2TotalEmployeeCnt
Subtotal Spent$21,774,944SubtotalSpentAmt
Total Spent$21,774,944TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (64 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtDescription Of Non Cash AsstDescriptionOfNonCashAsstTxtValuation Method UsedValuationMethodUsedDesc
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$195,000CHECK/WIREN/AN/A
East Asia and the PacificPREVENTION$37,185CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$120,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$705,195CHECK/WIREN/AN/A
Middle East and North Africa$62,853CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNOTHERAPIES$807,719CHECK/WIREN/AN/A
East Asia and the Pacific$574,445CHECK/WIREN/AN/A
East Asia and the PacificIMMUNOTHERAPIES$1,475,385CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$60,816CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNOTHERAPIES$63,529CHECK/WIREN/AN/A
East Asia and the PacificPREVENTION$160,000CHECK/WIREN/AN/A
North America$859,430CHECK/WIREN/AN/A
North AmericaBETA CELL REPLACEMENT$544,578CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$110,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$444,396CHECK/WIREN/AN/A
North AmericaBETA CELL REGENERATION$148,924CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$261,295CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL REGENERATION$146,601CHECK/WIREN/AN/A
East Asia and the PacificBETA CELL REPLACEMENT$109,994CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)TRANSPORTFOLIO$175,000CHECK/WIREN/AN/A
East Asia and the PacificPREVENTION$625,728CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$1,192,020CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)COMPLICATIONS$522,660CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL REGENERATION$26,949CHECK/WIREN/AN/A
North America$92,280CHECK/WIREN/AN/A
East Asia and the PacificPREVENTION$64,649CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$361,020CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THEPAPIES$318,106CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$489,216CHECK/WIREN/AN/A
East Asia and the PacificPREVENTION$30,221CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$248,430CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$119,821CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL$62,500CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$1,392,697CHECK/WIREN/AN/A
East Asia and the PacificIMMUNE THERAPIES$618,750CHECK/WIREN/AN/A
East Asia and the PacificARTIFICIAL PANCREAS$859,399CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL REPLACEMENT$521,988CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)METABOLIC CONTROL$154,085CHECK/WIREN/AN/A
East Asia and the PacificIMMUNE THERAPIES$484,125CHECK/WIREN/AN/A
North AmericaIMMUNE THERAPIES$80,550CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$413,423CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNE THERAPIES$62,640CHECK/WIREN/AN/A
East Asia and the PacificMISSION$600,000CHECK/WIREN/AN/A
East Asia and the PacificPREVENTION$69,060CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)$243,750CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$485,728CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$300,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)TRANSPORTFOLIO$287,643CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)METABOLIC CONTROL$199,927CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL REGENERATION$95,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)ARTIFICIAL PANCREAS$418,664CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)ARTIFICIAL PANCREAS$100,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)IMMUNOTHERAPIES$615,241CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL$250,000CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$249,808CHECK/WIREN/AN/A
Middle East and North AfricaARTIFICIAL PANCREAS$481,475CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)PREVENTION$315,621CHECK/WIREN/AN/A
East Asia and the PacificBETA CELL REPLACEMENT$109,963CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)TRANSPORTFOLIO$54,013CHECK/WIREN/AN/A
Middle East and North AfricaTRANSPORTFOLIO$333,060CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL REPLACEMENT$102,881CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)METABOLIC CONTROL, PREVENTION$330,777CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)BETA CELL REGENERATION$62,640CHECK/WIREN/AN/A
Europe (Including Iceland and Greenland)TRANSPORTFOLIO$125,000CHECK/WIREN/AN/A
FieldValueIRS element (for citing)
Total501c3 Org55Total501c3OrgCnt
Total Other Org9TotalOtherOrgCnt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (true)PassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceGRANT MONITORING PROCEDURESFormAndLineReferenceDesc
ExplanationSCH-F PART I LINE 2 RESEARCH GRANTS ARE AWARDED BY JDRF INTERNATIONAL WITH THE SUPPORT OF JDRFI'S RESEARCH COMMITTEE COMPRISED OF "JDRF INTERNATIONAL BOARD MEMBERS AND OTHER VOLUNTEERS" FOLLOWING THE RECOMMENDATIONS OF AN IN-HOUSE TEAM OF PROFESSIONAL SCIENTIFIC STAFF AND WITH INPUT FROM EXTERNAL SCIENTIFIC REVIEWERS. THE REVIEW PROCESS INCLUDES THE FOLLOWING CRITERIA: (1) THE SCIENTIFIC MERIT OF THE PROPOSED RESEARCH OUTLINED IN A GRANT APPLICATION AND (2) THE RELATIONSHIP OF THE PROPOSED RESEARCH TO JDRF'S GOAL TO IMPROVE LIVES TODAY AND TOMORROW BY ACCELERATING LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D AND ITS COMPLICATIONS. THE SCIENTIFIC RESEARCH TEAM AND GRANT ADMINISTRATION STAFF MAINTAIN CLOSE CONTACT WITH GRANTEES, PROVIDING ADVICE AND EVALUATION, REVIEWING PROGRESS REPORTS, REVIEWING RESEARCH EXPENDITURES VERSUS AGREED BUDGETS, AND HELPING DISSEMINATE RESEARCH RESULTS.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

FieldValueIRS element (for citing)
PersonCARS CHARITABLE ADULT RIDES AND SEPersonNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line14669 MURPHY CANYON RD STE 200AddressLine1Txt
CitySAN DIEGOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP92123ZIPCd
FieldValueIRS element (for citing)
ActivityCAR DONATIONActivityTxt
Fundraiser Control Of FundsYes (true)FundraiserControlOfFundsInd
Gross Receipts$137,540GrossReceiptsAmt
Retained By Contractor$27,446RetainedByContractorAmt
Net To Organization$110,094NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$137,540TotalGrossReceiptsAmt
Total Retained By Contractors$27,446TotalRetainedByContractorsAmt
Total Net To Organization$110,094TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDELicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1ILLINOIS GALAEvent1Nm
Gross Receipts Event1$7,154,385GrossReceiptsEvent1Amt
Charitable Contri Event1$6,250,224CharitableContriEvent1Amt
Gross Revenue Event1$904,161GrossRevenueEvent1Amt
Rent Facility Costs Event1$37,960RentFacilityCostsEvent1Amt
Food And Beverage Event1$325,914FoodAndBeverageEvent1Amt
Entertainment Event1$410,752EntertainmentEvent1Amt
Other Direct Expenses Event1$129,535OtherDirectExpensesEvent1Amt
Event2NYC/LI BALLEvent2Nm
Gross Receipts Event2$2,307,514GrossReceiptsEvent2Amt
Charitable Contri Event2$1,945,685CharitableContriEvent2Amt
Gross Revenue Event2$361,829GrossRevenueEvent2Amt
Non Cash Prizes Event2$1,189NonCashPrizesEvent2Amt
Food And Beverage Event2$170,959FoodAndBeverageEvent2Amt
Entertainment Event2$131,750EntertainmentEvent2Amt
Other Direct Expenses Event2$57,931OtherDirectExpensesEvent2Amt
Other Events Total0OtherEventsTotalCnt
Gross Receipts Other Events$118,358,113GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$101,369,344CharitableContriOtherEventsAmt
Gross Revenue Other Events$16,988,769GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events$223,503NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$1,153,201RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$1,824,097FoodAndBeverageOtherEventsAmt
Entertainment Other Events$2,757,216EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$11,030,752OthDirectExpnssOtherEventsAmt
Gross Receipts Total$127,820,012GrossReceiptsTotalAmt
Charitable Contributions Tot$109,565,253CharitableContributionsTotAmt
Gross Revenue Total Events$18,254,759GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$224,692NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$1,191,161RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$2,320,970FoodAndBeverageTotalEventsAmt
Entertainment Total Events$3,299,718EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$11,218,218OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$18,254,759DirectExpenseSummaryEventsAmt

Gaming Information GamingInformationGrp

FieldValueIRS element (for citing)
Gross Revenue Other Gaming$850,956GrossRevenueOtherGamingAmt
Non Cash Prizes Other Gaming$18,545NonCashPrizesOtherGamingAmt
Rent Fclty Costs Other Gaming$214,958RentFcltyCostsOtherGamingAmt
Volunteer Labor Other GamingfalseVolunteerLaborOtherGamingInd
Gross Revenue Total Gaming$850,956GrossRevenueTotalGamingAmt
Non Cash Prizes Total Gaming$18,545NonCashPrizesTotalGamingAmt
Rent Fclty Costs Total Gaming$214,958RentFcltyCostsTotalGamingAmt
Direct Expense Summary Gaming$233,503DirectExpenseSummaryGamingAmt
Net Gaming Income Summary$617,453NetGamingIncomeSummaryAmt
FieldValueIRS element (for citing)
States Where Gaming ConductedALStatesWhereGamingConductedCd
States Where Gaming ConductedAKStatesWhereGamingConductedCd
States Where Gaming ConductedAZStatesWhereGamingConductedCd
States Where Gaming ConductedARStatesWhereGamingConductedCd
States Where Gaming ConductedCAStatesWhereGamingConductedCd
States Where Gaming ConductedCOStatesWhereGamingConductedCd
States Where Gaming ConductedCTStatesWhereGamingConductedCd
States Where Gaming ConductedDEStatesWhereGamingConductedCd
States Where Gaming ConductedDCStatesWhereGamingConductedCd
States Where Gaming ConductedFLStatesWhereGamingConductedCd
States Where Gaming ConductedGAStatesWhereGamingConductedCd
States Where Gaming ConductedHIStatesWhereGamingConductedCd
States Where Gaming ConductedIDStatesWhereGamingConductedCd
States Where Gaming ConductedILStatesWhereGamingConductedCd
States Where Gaming ConductedINStatesWhereGamingConductedCd
States Where Gaming ConductedIAStatesWhereGamingConductedCd
States Where Gaming ConductedKSStatesWhereGamingConductedCd
States Where Gaming ConductedKYStatesWhereGamingConductedCd
States Where Gaming ConductedLAStatesWhereGamingConductedCd
States Where Gaming ConductedMEStatesWhereGamingConductedCd
States Where Gaming ConductedMDStatesWhereGamingConductedCd
States Where Gaming ConductedMAStatesWhereGamingConductedCd
States Where Gaming ConductedMIStatesWhereGamingConductedCd
States Where Gaming ConductedMNStatesWhereGamingConductedCd
States Where Gaming ConductedMSStatesWhereGamingConductedCd
States Where Gaming ConductedMOStatesWhereGamingConductedCd
States Where Gaming ConductedMTStatesWhereGamingConductedCd
States Where Gaming ConductedNEStatesWhereGamingConductedCd
States Where Gaming ConductedNVStatesWhereGamingConductedCd
States Where Gaming ConductedNHStatesWhereGamingConductedCd
States Where Gaming ConductedNJStatesWhereGamingConductedCd
States Where Gaming ConductedNMStatesWhereGamingConductedCd
States Where Gaming ConductedNYStatesWhereGamingConductedCd
States Where Gaming ConductedNCStatesWhereGamingConductedCd
States Where Gaming ConductedNDStatesWhereGamingConductedCd
States Where Gaming ConductedOHStatesWhereGamingConductedCd
States Where Gaming ConductedOKStatesWhereGamingConductedCd
States Where Gaming ConductedORStatesWhereGamingConductedCd
States Where Gaming ConductedPAStatesWhereGamingConductedCd
States Where Gaming ConductedRIStatesWhereGamingConductedCd
States Where Gaming ConductedSCStatesWhereGamingConductedCd
States Where Gaming ConductedSDStatesWhereGamingConductedCd
States Where Gaming ConductedTNStatesWhereGamingConductedCd
States Where Gaming ConductedTXStatesWhereGamingConductedCd
States Where Gaming ConductedUTStatesWhereGamingConductedCd
States Where Gaming ConductedVTStatesWhereGamingConductedCd
States Where Gaming ConductedVAStatesWhereGamingConductedCd
States Where Gaming ConductedWAStatesWhereGamingConductedCd
States Where Gaming ConductedWVStatesWhereGamingConductedCd
States Where Gaming ConductedWIStatesWhereGamingConductedCd
States Where Gaming ConductedWYStatesWhereGamingConductedCd
LicensedYes (true)LicensedInd
License Suspended EtcfalseLicenseSuspendedEtcInd
Gaming With NonmembersfalseGamingWithNonmembersInd
Member Of Other EntityfalseMemberOfOtherEntityInd
Gaming Other Facility1.00000GamingOtherFacilityPct
Individual With BooksEVAN CUCCHIAROIndividualWithBooksNm

Persons With Books US Address PersonsWithBooksUSAddress

FieldValueIRS element (for citing)
Address Line1200 VESEY STREET 28TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10281ZIPCd
FieldValueIRS element (for citing)
Cntrct With3rd Prty For Game RevfalseCntrctWith3rdPrtyForGameRevInd
Gaming Manager PersonEVAN CUCCHIARO SR ACCOUNTANT -JDGamingManagerPersonNm
Gaming Manager Compensation$0GamingManagerCompensationAmt
Gaming Manager Services ProvFILING GAMING APPLICATIONS AND REPORTSGamingManagerServicesProvTxt
Gaming Manager Is EmployeeYes (X)GamingManagerIsEmployeeInd
Charitable Distribution RqrfalseCharitableDistributionRqrInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE G, PART I, LINE 2FormAndLineReferenceDesc
ExplanationCHARITABLE ADULT RIDES AND SERVICES (CARS) IS A STATE LICENSED PROFESSIONAL FUNDRAISER THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CONTACT THE COMPANY DIRECTLY THROUGH A TOLL FREE NUMBER TO COORDINATE THE DONATION, FOLLOWING WHICH INSURANCE AUTO AUCTIONS HANDLES ALL REQUIRED IRS 1098C REPORTING. FOR THE PERIOD ENDING 6/30/20, THE CAR PROGRAM RAISED $137,540 WITH TOTAL EXPENSES OF $27,446 WITH THE NET PROCEEDS OF $110,094 PROVIDED DIRECTLY TO JDRF. JDRF PAYS NO ADDITIONAL EXPENSES OR FEES TO INSURANCE AUTO AUCTIONS FOR THIS PROGRAM.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (75 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtValuation Method UsedValuationMethodUsedDescNon Cash AssistanceNonCashAssistanceDescPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
BENAROYA RESEARCH INST AT VIRGINIA MASON
1201 9TH AVESEATTLEWA98101910653422501(C)3$1,651,931N/AN/A
ANN AND ROBERT LURIE CHILDREN'S HOSPITAL
225 EAST CHICAGO AVENUECHICAGOIL60611362170833501(C)3$175,245N/AN/APSYCHOSOCIAL
CAM MED LLC
29 EXETER STREETWEST NEWTONMA02465464517489$198,467N/AN/AIMMUNE THERAPIES
UNIVERSITY OF ARIZONA
PO Box 245049TUCSONAZ850044593113661893501(C)3$450,000N/AN/AARTIFICIAL PANCREAS
CRITICAL PATH INSTITUTE
1730 EAST RIVER ROADTUCSONAZ85718201991334501(C)3$164,000N/AN/A
INDIANA UNIVERSITY
980 INDIANA AVENUEINDIANAPOLISIN46202356018940501(C)3$938,214N/AN/ABETA CELL REGENERATION
JOSLIN DIABETES CENTER
1 JOSLIN PLBOSTONMA02215042203836501(C)3$1,621,981N/AN/ACOMPLICATIONS
FREQUENCY THERAPEUTICS
300 TECHNOLOGY SQUAREWOBURNMA01801472324450$87,440N/AN/A
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVECAMBRIDGEMA02139042103594501(C)3$12,049N/AN/A
INDIANA BIOSCIENCES RES INST
1345 W 16TH STREETINDIANAPOLISIN46202462882271501(C)3$366,810N/AN/ABETA CELL REGENERATION
MAYO CLINIC
1216 2ND ST SWROCHESTERMN55902411405254501(C)3$250,611N/AN/AIMMUNE THERAPIES
GEORGIA TECH RESEARCH CORP
505 TENTH STREETATLANTAGA30332580603146501(C)3$326,261N/AN/AIMMUNE THERAPIES
STANFORD UNIVERSITY
291 CAMPUS DRIVESTANFORDCA94305941156365501(C)3$736,781N/AN/ABETA CELL REGENERATION
NEW YORK STEM CELL FOUNDATION
619 WEST 54TH STREETNEW YORKNY10019202905531501(C)3$449,999N/AN/ABETA CELL REGENERATION
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSONPORTLANDOR97239237083114501(C)3$404,294N/AN/APSYCHOSOCIAL
IBM
1 N CASTLE DRARMONKNY10504130871925$1,125,000N/AN/APREVENTION
PACIFIC DIABETES TECHNOLOGIES
12154 SW GARDEN PLACEPORTLANDOR97223000000000501(C)3$220,689N/AN/A
UNIVERSITY OF FLORIDA
1600 SW ARCHER ROADGAINESVILLEFL32610590974739501(C)3$1,413,091N/AN/ABETA CELL REPLACEMENT
UNIVERSITY OF VIRGINIA
104 MIDMONT LNCHARLOTTESVILLEVA22902416042488501(C)3$67,817N/AN/AARTIFICIAL PANCREAS
UNIVERSITY OF MICHIGAN
2003 S STATE STREETANN ARBORMI48109386006309501(C)3$2,421,363N/AN/ABETA CELL REPLACEMENT
LOCKHEED MARTIN
199 BORTON LANDING RDMOORESTOWNNJ08057521893632$87,304N/AN/AIMMUNE THERAPIES
UNIVERSITY OF CALIFORNIA
3333 CA STSAN FRANCISCOCA94122956006143501(C)3$3,650,559N/AN/AIMMUNOTHERAPIES
UT SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVDDALLASTX75390756002868501(C)3$252,250N/AN/A
VANDERBILT UNIVERSITY MEDICAL CENTER
1211 MEDICAL CENTER DRNASHVILLETN37232620476822501(C)3$1,016,666N/AN/ABETA CELL REGENERATION
LOUISIANA STATE UNIV HEALTH SCIENCE
433 BOLIVAR STREETNEW ORLEANSLA70112270158443501(C)3$125,000N/AN/AIMMUNE THERAPIES
JAEB CENTER FOR HEALTH RESEARCH FND
15310 Amberly DriveTAMPAFL33647593187624501(C)3$1,907,184N/AN/ATRANSPORTFOLIO
VIACYTE INC
3550 GENERAL ATOMICSSAN DIEGOCA92121330884172$650,000N/AN/ABETA CELL REGENERATION
COLUMBIA UNIVERSITY
535 W 116TH STNEW YORKNY10027135598093501(C)3$62,640N/AN/AIMMUNOTHERAPIES
YALE UNIVERSITY
PO BOX 209010NEW HAVENCT06520060646973501(C)3$866,764N/AN/APREVENTION
SFC FLUIDICS INC
534 WEST RES CENTERFAYETTEVILLEAR72701113682226$872,538N/AN/AARTIFICIAL PANCREAS
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1720 2ND AVS SBIRMINGHAMAL35294636001138501(C)3$372,551N/AN/A
NORTHWESTERN UNIVERSITY
633 CLARK STREETEVANSTONIL60208231352685501(C)3$66,900N/AN/AIMMUNOTHERAPIES
ICAHN SCHOOL OF MEDICINE MOUNT SINAI
1 GUSTAVE L LEVY PLACENEW YORKNY10029136171197501(C)3$867,090N/AN/AARTIFICIAL PANCREAS
STATE UNIVERSITY OF NY AT BUFFALO
12 CAPEN HALLBUFFALONY14260141368361501(C)3$667,124N/AN/A
UNIVERSITY OF MINNESOTA
200 OAK ST SEMINNEAPOLISMN55455416007513501(C)3$2,063,899N/AN/AARTIFICIAL PANCREAS
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVE NESEATTLEWA98195911486484501(C)3$250,000N/AN/A
THE MEDICAL COLLEGE OF WISCONSIN
8701 W WATERTOWNMILWAUKEEWI53226611730890501(C)3$584,260N/AN/AIMMUNE THERAPIES
TIDEPOOL
555 BRYANTST PALO ALTOCA94301462302287$650,000N/AN/AARTIFICIAL PANCREAS
UNIVERSITY OF UTAH
201 PRESIDENTS CRSALT LAKE CITYUT84112876000525501(C)3$765,065N/AN/AIMMUNOTHERAPIES
PROTOMER TECHNOLOGIES
530 SOUTH LAKE AVEPASADENACA91101474206994$356,314N/AN/AIMMUNE THERAPIES
UNIVERSITY OF COLORADO
1800 GRANT STREETDENVERCO80203846049811501(C)3$3,623,140N/AN/APREVENTION
UNIVERSITY OF ILLINOIS
1200 HARRISONCHICAGOIL60612376006007501(C)3$771,252N/AN/AARTIFICIAL PANCREAS
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
1 COLLEGE HALLPHILADELPHIAPA19104231352685501(C)3$42,621N/AN/AIMMUNE THERAPIES
UNIVERSITY OF TEXAS HEALTH SCIENCE
7703 FLOYD CURL DRIVESAN ANTONIOTX78229741586031501(C)3$480,505N/AN/AMETABOLIC CONTROL
WASHINGTON UNIVERSITY
One Brookings DriveSt LouisMO63130430653611501(C)3$542,203N/AN/ABETA CELL REPLACEMENT
VTV THERAPEUTICS LLC
4170 MENDENHALL OAKSHIGH POINTNC27265113682226$600,000N/AN/AIMMUNE THERAPIES
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVENUEBOSTONMA02115043266103501(C)3$1,859,050N/AN/ABETA CELL REPLACEMENT
HARVARD COLLEGE
677 HUNTINGTON AVEBOSTONMA02115042103580501(C)3$4,312,693N/AN/ABETA CELL REPLACEMENT
IVIVA MEDICAL INC
100 CUMMINGS CENTERBEVERLYMA01915000000000$45,000N/AN/ABETA CELL REPLACEMENTSUITE 451C
JOHNS HOPKINS UNIVERSITY
3400 N CHARLES STREETBALTIMOREMD21218520595110501(C)3$13,638N/AN/AIMMUNOTHERAPIES
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
1 LETTERMAN DR STE D3500SAN FRANCISCOCA94129473355381501(C)3$1,106,749N/AN/A
PHYSIOLOGIC DEVICES INC
2232 OLD STAGECOACH TRAILALPINECA91901000000000$962,000N/AN/A
SINCLAIR RESEARCH CENTER LLC
562 STATE ROAD DDAUXVASSEMO65231000000000$122,027N/AN/A
STOWERS INSTITUTE FOR MEDICAL RESEARCH
1000 EAST 50TH STREETKANSAS CITYMO64110202993509501(C)3$147,893N/AN/A
THE OHIO STATE UNIVERSITY
281 W LANE AVECOLUMBUSOH43210261416129501(C)3$185,000N/AN/A
THE SCRIPPS RESEARCH INSTITUTE
10550 N TORREY PINES RDLA JOLLACA92037330435954501(C)3$441,100N/AN/ABETA CELL REGENERATION
THE UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
1000 STANTON L YOUNG BLVDOKLAHOMA CITYOK73104731563627501(C)3$250,000N/AN/ACOMPLICATIONS
UNIVERSITY OF MIAMI
1320 S DIXIE HWY STE 760CORAL GABLESFL33146590624458501(C)3$467,579N/AN/ABETA CELL REPLACEMENT
UNIVERSITY OF NEBRASKA BOARD OF REGENTS
3835 HOLDREGELINCOLNNE68583470049123501(C)3$349,998N/AN/APREVENTIONVARNER HALL
VANDERBILT UNIVERSITY
2301 VANDERBILT PLACENASHVILLETN37240620476822501(C)3$262,640N/AN/AMETABOLIC CONTROL
WAVE 80 BIOSCIENCES
2325 THIRD STSAN FRANCISCOCA94107000000000$39,992N/AN/APREVENTIONSUITE 215
ADVANCED REGENERATIVE MANUFACTURING INSTITUTE
400 COMMERCIAL STREETMANCHESTERNH03101813327581501(C)(3)$1,279,011N/AN/ABETA CELL REPLACEMENT
ALBERT EINSTEIN COLLEGE OF MEDICINE INC
1300 MORRIS PARK AVENUEBRONXNY10461472209056$110,000N/AN/AIMMUNOTHERAPIESBELFER 312
ARIZONA STATE UNIVERSITY
PO Box 873503TEMPEAZ85281860196696501(C)(3)$110,000N/AN/ABETA CELL REPLACEMENT
BALLAD RESEARCH INSTITUTE
10865 ROAD TO THE CURESAN DIEGOCA921211155611771290501(C)(3)$250,000N/AN/AIMMUNOTHERAPIES
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RDDUARTECA91010953432210501(C)(3)$402,643N/AN/ABETA CELL REGENERATION
CHILDREN'S HOSPITAL OF PHILADELPHIA
3401 CIVIC CTR BLVDPHILADELPHIAPA19104232237932501(C)(3)$149,999N/AN/APREVENTION
COLORADO SCHOOL OF MINES
1500 ILLINOIS STGOLDENCO80401846000551501(C)(3)$109,984N/AN/ABETA CELL REGENERATION
IQVIA INC
4820 EMPEROR BLVDDURHAMNC27703271341991$198,500N/AN/APREVENTION
O2M TECHNOLOGIES LLC
HTI ENTERPRISEWORKSCHICAGOIL60612000000000$512,762N/AN/ABETA CELL REPLACEMENT2242 W HARRISON ST STE 201-18
SAB BIOTHERAPEUTICS INC
2301 E 60TH ST NSIOUX FALLSSD57104000000000$100,000N/AN/AIMMUNOTHERAPIES
SAINT LOUIS UNIVERSITY
1 N GRAND BLVDSAINT LOUISMO63103430654872501(C)(3)$110,000N/AN/AMETABOLIC CONTROL
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111475074602501(C)(3)$25,000N/AN/ATRANSPORTFOLIO5TH FL
UNIVERSITY OF NOTRE DAME
182 FITZPATRICK HALLNOTRE DAMEIN46556350868188501(C)(3)$150,000N/AN/AMETABOLIC CONTROL
UNIVERSITY OF PITTSBURGH
4200 FIFTH AVEPITTSBURGHPA15260250965591501(C)(3)$475,610N/AN/APREVENTIONCENTRAL PLANT NO 3
FieldValueIRS element (for citing)
Total501c3 Org58Total501c3OrgCnt
Total Other Org17TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceGRANT MONITORING PROCEDURESFormAndLineReferenceDesc
ExplanationSCH-I PART I LINE 2 RESEARCH GRANTS ARE AWARDED BY JDRF INTERNATIONAL WITH THE SUPPORT OF JDRFIs RESEARCH COMMITTEE COMPRISED OF "JDRF INTERNATIONAL BOARD MEMBERS AND OTHER VOLUNTEERSTHE JDRF INTERNATIONAL BOARD OF DIRECTORS FOLLOWING THE RECOMMENDATIONS OF AN IN-HOUSE TEAM OF PROFESSIONAL SCIENTIFIC STAFF AND WITH INPUT FROM EXTERNAL SCIENTIFIC REVIEWERS. THE REVIEW PROCESS INCLUDES THE FOLLOWING CRITERIA: (1) THE SCIENTIFIC MERIT OF THE PROPOSED RESEARCH OUTLINED IN A GRANT APPLICATION AND (2) THE RELATIONSHIP OF THE PROPOSED RESEARCH TO JDRF'S GOAL TO IMPROVE LIVES TODAY AND TOMORROW BY ACCELERATING LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D AND ITS COMPLICATIONS. THE SCIENTIFIC RESEARCH TEAM AND GRANT ADMINISTRATION STAFF MAINTAIN CLOSE CONTACT WITH GRANTEES, PROVIDING ADVICE AND EVALUATION, REVIEWING PROGRESS REPORTS, REVIEWING RESEARCH EXPENDITURES VERSUS AGREED BUDGETS, AND HELPING DISSEMINATE RESEARCH RESULTS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredfalseSubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
AARON KOWALSKI
PRESIDENT AND CEO$460,000$0$140,000$0$54,519$0$12,375$0$33,917$0$700,811$0$0$0
SANDRA HIJIKATA THRU 0420
CHIEF DEV OFFICER & ASST. SECY$378,750$0$71,800$0$0$12,375$0$12,569$0$475,494$0$0$0
JILL CLARK
SVP, VOLUNTEER ENGAGEMENT$285,000$0$74,900$0$0$0$12,375$0$7,213$0$379,488$0$0$0
ALISA NORRIS
CHIEF MARKETING OFFICER$360,000$0$15,000$0$0$12,375$0$34,613$0$421,988$0$0$0
SUSAN YUN THRU 0520
CHIEF PEOPLE OFFICER/ASST. SEC$298,333$0$75,100$0$0$0$12,375$0$2,598$0$388,406$0$0$0
CYNTHIA RICE
CHIEF MISSION OFFICER$298,034$0$72,800$0$0$12,375$0$18,777$0$401,986$0$0$0
JOANNE MARTZ
CFO/TREASURER$353,333$0$62,800$0$0$9,987$0$24,929$0$451,049$0$0$0
HELEN ELIAS
MANAGING DIR. JDRF T1D FUND$260,350$0$153,800$0$36,348$0$0$25,833$0$476,331$0$0$0
SYDNEY YOVIC
CHIEF OF STAFF/ASST. TREASURER$165,985$0$19,100$0$0$8,140$0$24,844$0$218,069$0$0$0
DEREK RAPP THRU 0419
PRESIDENT AND CEO$215,158$0$270,828$0$384,385$0$0$0$11,538$0$881,909$0$0$0
SRINIVAS MISHRA
CHIEF DATA AND TECHNOLOGY$312,667$0$50,400$0$0$24,929$0$9,132$0$397,128$0$0$0
SANJOY DUTTA
VP, RESEARCH$256,771$0$29,400$0$0$12,338$0$3,817$0$302,326$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
HOUSING ALLOWANCESCHEDULE J PART I, LINE 1A Pres & CEO Aaron Kowalski and Managing Director of the JDRF T1D Fund Helen Elias both received a housing allowance as per the terms of their employment agreements. The totals for both are as follows: Aaron Kowalski - $54,519 Helen Elias - $36,348 For the 2019 calendar year, the housing allowance provided to Derek Rapp was $25,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B) (III).
NON-FIXED PAYMENTSFORM 990, SCHEDULE J, PART I, LINE 7 JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II).
SEVERANCE PAYMENTSSCHEDULE J, PART I, LINE 4A DEREK RAPP RECEIVED A SEVERANCE PAYMENT OF $359,385 WHICH IS REPORTED ON SCHEDULE J, PART II, COL. (B)(III) OTHER REPORTABLE COMPENSATION.

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp

Cars And Other Vehicles CarsAndOtherVehiclesGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution5ContributionCnt
Noncash Contributions Rpt F990$223,503NoncashContributionsRptF990Amt
Method Of Determining RevenuesAPPRAISALMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution328ContributionCnt
Noncash Contributions Rpt F990$5,097,576NoncashContributionsRptF990Amt
Method Of Determining RevenuesNET PROCEEDS OF SALEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescMISC AUCTION ITEMS DONATEDDesc
Contribution14900ContributionCnt
Noncash Contributions Rpt F990$6,839,325NoncashContributionsRptF990Amt
Method Of Determining RevenuesFAIR MARKET VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (true)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
THIRD PARTY ASSISTANCELINE 32B CHARITABLE ADULT RIDES AND SERVICES (CARS) IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, CARS HANDLES ALL IRS 1098-C REPORTING. CARS IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/20, CARS RAISED $137,740 WITH TOTAL EXPENSES OF $27,446. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY CARS ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-20 WAS $110,094.
NONCASH CONTRIBUTIONSFORM 990, SCHEDULE M, PAGE 1 TYPES OF PROPERTY AND THE AMOUNTS LISTED IN PART I LINES 6, 9, and 25 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES, SECURITIES, AND MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS & RAFFLES.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PUBLIC DOCUMENTSFORM 990, PAGE 6, PART VI, SECTION C, LINE 19 The organization makes its governing documents, conflict of interest policy and financial statements available to the public on its website: www.JDRF.org. The public may access copies of JDRF's W-9, annual reports, 990 tax returns, 501(c)(3) IRS letter, and audited financials, at the following link: www.jdrf.org/about/financials
EXECUTIVE COMPENSATION POLICYPART VI, SECTION B, LINES 15a & 15b JDRF's Board of Directors charges a Talent and Compensation Committee to develop and recommend a compensation philosophy that applies to all employees of JDRF, including recommendations regarding the compensation and benefits of JDRF senior management for approval by the Board of Directors. The Committee works in collaboration with the President and CEO and the Chief People Officer and other senior staff personnel in the JDRF Human Resources Department to ensure that 1) the Foundation's talent strategy supports and is aligned with its overall organization strategies; 2) JDRF is in compliance with IRS guidelines for determining reasonableness in pay practices; and 3) overall compensation for JDRF's key executives is competitive and aligned with pay philosophy. To attract and retain top scientific and executive talent to advance its mission, the organization pays competitive and appropriate salaries as determined by analysis of reliable data and input from independent third-party consultants. The review of JDRF executive compensation and benefits under the procedures noted above is completed annually by an independent Compensation Committee, and the basis for their determination is documented contemporaneously in the minutes of the Committee's meetings, including most recently on June 30, 2020.
FORM 990 REVIEW PROCESSSECTION B, PART VI, QUESTION 11B JDRF has a rigorous standard approach to reviewing its 990. The Organization's Senior Accountant works with its outside tax preparers to prepare the return and all supporting schedules. The draft return is reviewed by a number of individuals, including JDRF's Chief Financial Officer and AVP, FINANCE, the Chief Executive Officer, other executives, its external senior tax advisor and others as necessary to ensure accuracy. Any questions and changes with respect to the draft return are addressed. Following this process, the return is reviewed by JDRF's Audit Committee of the Board of Directors with its outside tax advisors. Once approved, the return is distributed to all members of JDRF's Board of Directors for review and comment before it is filed with the Internal Revenue Service.
PART III: STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTSLINE 4A ($68,847,301) RESEARCH GRANTS JDRF has played a significant role in nearly every T1D therapeutic advance made in the last 50 years. Our funding supports more than 500 active T1D research grants in the United States and 21 other countries around the world including more than 150 grants in 2020 alone, plus 75 clinical trials. We leverage partnerships with academia, industry and clinicians to accelerate the most promising research opportunities. Our highest priority is developing cures for T1D and improving lives of those living with the disease today, including research in glucose control and prevention of T1D complications. The full impact of JDRF's research investment extends well beyond direct funding. Through advocacy and influence, JDRF drives funding from other sources into the T1D research and has helped secure passage of the Special Diabetes Program, putting more than $3 billion in federal funding toward T1D research over the last two decades. In addition, JDRF founded the JDRF T1D Fund (www.t1dfund.org). The wholly owned subsidiary of JDRF, the Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent and cure T1D through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines to help people living with T1D or at risk of developing the disease. The T1D Fund invests in opportunities that drive our mission, with an exclusive focus on the best commercial opportunities. All funds go directly to support companies developing approaches to treat, prevent and cure T1D. In accordance with GAAP, $50MM of the T1D Fund's total investments as of June 30, 2020 are reflected in the Balance Sheet (Part X) and not included within the organization's research-related mission expense. The foundation's diversified research portfolio includes a focus on Curing T1D and Improving Lives. Curing T1D We face two key challenges in Curing T1D. We must prevent, stop or reverse: the loss of insulin-producing beta cells, and the immune systems attack on beta cells. JDRF is accelerating our work in Curing T1D by focusing on the two areas that have advanced dramatically over the last years: Beta Cell Therapies and Immune Therapies. Beta Cell Therapies: focus on replacing insulin-producing beta cells from outside sources and on internally regenerating and protecting existing beta cells. Through donor-funded research, we now know that when someone has T1D, their own body turns on itself, attacking and destroying the beta cells that create insulin. Understanding the role of beta cells -- was a breakthrough. If we can save beta cells, we can help cure T1D. Immune Therapies: focus on ways to keep the immune system from attacking and destroying beta cells, and to prevent the onset and advancement of T1D. Research has shown that immune therapies can interact with a persons immune system, training it to combat internal battles like cancer or autoimmune diseases like rheumatoid arthritis and T1D. While T1D remains one of the only major autoimmune diseases without an effective drug therapy, we know we are getting close. Improving Lives T1D brings with it daily struggles and stress that that make the challenges of living a healthy and long life with T1D very real. JDRF fights every day to advance research and technology that can reduce the burden of living with T1D and keep people as healthy as possible until we find cures. Specifically, we are striving to improve lives by driving research and work in Glucose Control Therapies and Complications Therapies which includes psychosocial well-being. Glucose Control Therapies: focus on helping those with T1D manage glucose levels and overall metabolic balance, including improved artificial pancreas technology, developing next-generation insulins and developing new drugs that control glucose in novel ways. We know that less than 30% of people with T1D in the U.S. consistently maintain target blood-glucose control levels meaning that 70% are at risk of serious health issues. Aiming to ensure our community is healthy when cures are found, we will continue our focus on bringing new innovation to this area, including improved artificial pancreas technology, next-generation insulins and new drugs that control glucose in novel ways. Complications Therapies: focus on accelerating therapies to prevent and treat kidney and eye disease and improving psychosocial well-being. We know that more than 90% of people with T1D develop eye disease within 20 years of diagnosis and that 1 in 4 develop kidney disease. We also know that prevalence of suicide is higher among young adults with T1D. Our focus on complications will be on accelerating therapies that prevent and treat kidney and eye disease. We also are expanding our support of psychosocial wellbeing. We have been supporting research of psychosocial wellbeing for several years. Now we are increasing our support as early research has shown that the burden of living with T1D takes a toll well beyond physical complications. Research also has shown us that young adults and teens with T1D are often impacted the most, with a significantly higher suicide rate. This is alarming and is our call to step up this work to help make a positive difference. LINE 4B ($16,997,889) RESEARCH SUPPORT JDRF's in-house team of skilled and credentialed scientific, policy and government relations professionals play critical roles in leading and supporting the research strategy and distribution of research funds from JDRF - and our partner organizations toward creating a world without T1D. Our professionals identify, evaluate and influence groundbreaking research for funding and work with other foundations, governments and industry to accelerate the mission we all share. JDRF professionals work with regulatory and policy officials to ensure research can proceed without delay and that advances are well understood by healthcare decision makers. As part of these efforts, JDRF organizes and funds scientific meetings, symposia, and conferences to review research proposals, ensure that JDRF's research strategy is aligned with the needs of the T1D community, and allow JDRF to provide scientific updates on the research it manages. This effort ensures that all the research is continually shared and built upon by T1D researchers around the globe. The Strategic Advisory Panel is composed of five established T1D experts in various aspects of the field, including pediatric endocrinology, prevention and treatment of T1D, immunotherapies, regulatory and drug development. The SAP contributes to JDRF scientists strategic planning around research funding goals and priorities. JDRF's work to bring together the best minds in the field enhances JDRF's ability to forecast future scientific direction, judge the potential effectiveness of new pathways, and identify gaps where JDRF funding can make the most impact. LINE 4C ($50,681,132) PUBLIC EDUCATION JDRF is uniquely qualified to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people living with T1D, their families and the general public, but also those at risk for developing the disease. T1D strikes both children and adults suddenly, and the critical adjustment period following a diagnosis can be overwhelming. That's why we support families navigating this challenging time. JDRF also educates people about the warning signs of T1D, aimed at ensuring timely diagnoses and reducing the potential catastrophic consequences of undiagnosed T1D. JDRF also provides information and updates about current research directions and progress and about human clinical trials that are seeking participants (including through JDRF's Clinical Trials Connection matching tool: www.jdrf.org/research/clinical-trials). Through all of our national U.S. chapters; five international affiliates in Australia, Canada, Israel, the Netherlands and United Kingdom; the 30,000 members of our social network, TypeOneNation; and more than one million supports, JDRF fights to meet T1D community's diverse needs, connecting people with local support, expert resources, and the global effort to create a world without T1D.
CONFLICT OF INTEREST POLICYFORM 990- PART VI-SECT B, LINE 12C All officers, directors, key employees, board and committee members (both chapters and international boards) are required to sign a conflict of interest policy annually and disclose any conflicts. The Office of the President and CEO manages this process, and JDRF's internal audit department annually audits to ensure compliance. If any conflict does arise, the board members with the conflicts will recuse themselves from the meeting and/or vote.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1JDRF T1D FUND LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1C/O JDRF - 200 VESEY STREET 28TH FLAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10281ZIPCd
FieldValueIRS element (for citing)
EIN274967989EIN
Primary ActivitiesFUNDR/INVESTPrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd
Total Income$23,329,961TotalIncomeAmt
End Of Year Assets$98,752,344EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1JDRFBusinessNameLine1Txt

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1CHARITABLE REMAINDER TRUST (5)BusinessNameLine1Txt
FieldValueIRS element (for citing)
Primary ActivitiesANNUITYPrimaryActivitiesTxt
Legal Domicile StatePALegalDomicileStateCd
Controlled OrganizationYes (true)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgfalseGiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesfalseSharingOfFacilitiesInd
Paid Employees SharingfalsePaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE R, PART I, LINE (1B)FormAndLineReferenceDesc
ExplanationTHE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS.ExplanationTxt